2025.04.27 (일)

  • 구름조금동두천 8.8℃
  • 구름많음강릉 17.8℃
  • 맑음서울 10.9℃
  • 구름많음대전 11.2℃
  • 구름많음대구 12.2℃
  • 구름많음울산 15.4℃
  • 구름많음광주 11.8℃
  • 흐림부산 14.6℃
  • 흐림고창 7.8℃
  • 구름많음제주 12.9℃
  • 구름많음강화 12.2℃
  • 구름많음보은 5.4℃
  • 구름많음금산 6.6℃
  • 구름많음강진군 8.2℃
  • 구름많음경주시 8.5℃
  • 구름많음거제 9.8℃
기상청 제공

경제

Synergy Pharmaceuticals Announces Closing of Public Offering of Shares of Common Stock

[By NBC-1TV H. J Yook]Synergy Pharmaceuticals Inc.(Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, announced the closing of its underwritten public offering of 16,375,000 shares of common stock at an offering price of $5.50 per share. Synergy received net proceeds, after deducting the underwriting discount and estimated offering expenses, of approximately $84.5 million. Synergy has also granted the underwriters a 30-day option to purchase up to an additional 2,456,250 shares of common stock to cover over-allotments, if any.

Synergy intends to use the net proceeds from this offering to fund its research and development activities, including further clinical development of plecanatide and its other pipeline programs, for working capital, other general corporate purposes, and possibly acquisitions of other companies, products or technologies, though no such acquisitions are currently contemplated.

Credit Suisse, Citigroup and Canaccord Genuity are acting as book-running managers in this offering, and Cantor Fitzgerald is acting as a co-manager.



배너

관련기사


배너
배너
배너
배너
배너
배너
배너
배너
배너
배너
배너
배너